02.07.2020 14:17:57
|
Centogene Obtains FDA Emergency Use Authorization For COVID-19 Molecular Diagnostic Test
(RTTNews) - Centogene N.V. (CNTG) said that the U.S. Food and Drug Administration has issued Emergency Use Authorization for the company's SARS-CoV-2 RT-PCR test.
The company noted that its SARS-CoV-2 RT-PCR test is a real-time test based on the reverse transcription polymerase chain reaction (RT-PCR) for the qualitative detection of SARS-CoV-2, the underlying virus causing COVID-19.
The test is intended for use by qualified laboratory personnel to be performed in Centogene's CLIA certified high-complexity laboratories in Germany, the company said.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Centogenemehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Centogenemehr Analysen
Aktien in diesem Artikel
Centogene | 0,14 | 7,92% |
|